TK

Tim Kutzkey

Managing Partner at The Column Group

San Francisco, California

Investor
VC

Invests in

Stages:

Seed
Series B
Series A

Sectors:

Pharmaceuticals
Consumer Health
Digital Health
Health & Hospital Services
BioTech
Health IT
San Francisco Bay Area

Locations:

San Francisco Bay Area
  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

  • Uo

    Ph.D.

    University of California, Berkeley

    (1999 - 2005)

  • SU

    Stanford University

    (1993 - 1997)

Lists including Tim

AH
AE
AF
AJ

Based in SF

3077 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Atavistik Bio

Series A

Total Funding: $100M

Kimia Therapeutics

Series A

Total Funding: $55M

Synthekine

Series A

Total Funding: $290M

Cajal Neuroscience

Series A

Total Funding: $96M

Plexium

Series B

Total Funding: $140M

Kallyope

Series D

Total Funding: $480M

Surrozen

Series A

Total Funding: $130M

Cyterix Pharmaceuticals

Series A

Total Funding: $9M

Work Experience

TC
The Column Group

2007

  • Managing Partner

    2007

KAI Pharmaceuticals

2006 - 2007

  • Scientist

    2006 - 2007

UB
UC Berkeley

2005 - 2006

  • Post-doc

    2005 - 2006

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.